C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 495/04 (2006.01) A61K 31/519 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2656364
The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula (I): Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
L'invention concerne des composés comprenant les énantiomères résolus, les diastéréoisomères, les solvates et les sels pharmaceutiquement acceptables de ceux-ci, représentés par la Formule (I) : L'invention concerne également des procédés d'utilisation de cette invention comme inhibiteurs de l'AKAT protéine kinase et pour le traitement de maladies hyperprolifératives telles que le cancer.
Bencsik Josef R.
Blake James F.
Kallan Nicholas C.
Mitchell Ian S.
Spencer Keith Lee
Array Biopharma Inc.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Dihydrothieno pyrimidines as akt protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydrothieno pyrimidines as akt protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydrothieno pyrimidines as akt protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1737852